1. Preliminary results show Chinese COVID-19 vaccine candidate safe: The Lancet_china.org.cn  China.org.cn
  2. China rapidly expands use of experimental COVID-19 vaccines  The Indian Express
  3. Covid-19 vaccine offered by Chinese city for emergency use costs $60  Hindustan Times
  4. China's Covid-19 Vaccine 'BBIBP-CorV' is Safe, Prompts Antibody Response: Lancet Study  News18
  5. Sinovac coronavirus vaccine offered by Chinese city for emergency use costs $60  Mint
  6. View Full coverage on Google News

Preliminary results show Chinese COVID-19 vaccine candidate safe: The Lancet - China.org.cn

China has said that while reasonable profits for companies are permitted, covid-19 vaccines should be priced close to cost.Chinese authorities have to date not released pricing details for potential covid-19 vaccinesChina has said that while reasonable profits for companies are permitted, covid-19 vaccines should be priced close to cost.Chinese authorities have to date not released pricing details for potential covid-19 vaccines

Sinovac coronavirus vaccine offered by Chinese city for emergency use costs $60

The second phase of the study was designed to identify the optimal timing schedule for vaccination.The second phase of the study was designed to identify the optimal timing schedule for vaccination.

The Beijing-based Sinovac Biotech’s vaccine — called CoronaVac — is being offered in the city of Jiaxing to care givers, especially epidemic-prevention workers, public service personnel and port inspectors, and will eventually be offered to regular citizens, the state media reported on Friday, quoting officials.The Beijing-based Sinovac Biotech’s vaccine — called CoronaVac — is being offered in the city of Jiaxing to care givers, especially epidemic-prevention workers, public service personnel and port inspectors, and will eventually be offered to regular citizens, the state media reported on Friday, quoting officials.

Sinovac vaccine for Covid offered by Chinese city for emergency use costs $60 - world news - Hindustan Times

A Chinese COVID-19 vaccine candidate based on the inactivated whole SARS-CoV-2 virus is safe and eli

Preliminary results show Chinese COVID-19 vaccine candidate safe: The Lancet - SHINE News

Inspections will be carried out at 3 companies that have agreed to supply COVID-19 vaccines to Indonesia - Anadolu AgencyInspections will be carried out at 3 companies that have agreed to supply COVID-19 vaccines to Indonesia - Anadolu Agency

Indonesian team in China to check COVID-19 vaccines

50 African diplomats visited China’s human vaccine research, development, and manufacturing enterprise Sinopharm in the fight against covid-1950 African diplomats visited China’s human vaccine research, development, and manufacturing enterprise Sinopharm in the fight against covid-19

50 African Diplomats on Anti-Covid-19 Visit to China’s Sinopharm | Africanews

Chinese drug companies have five vaccines in final stages of testing but none is approved for public use. They are part of a global race to develop a vaccine that, if successful, offers the fledgling Chinese industry the potential for prestige and worldwide sales.Chinese drug companies have five vaccines in final stages of testing but none is approved for public use. They are part of a global race to develop a vaccine that, if successful, offers the fledgling Chinese industry the potential for prestige and worldwide sales.

Covid-19: China rapidly expands use of its experimental coronavirus vaccines - World News

Russian Ambassador to Indonesia Lyudmila Vorobieva said her government had contacted the Health Ministry about the possible distribution and use of the Sputnik V vaccine and was currently waiting for its response.Russian Ambassador to Indonesia Lyudmila Vorobieva said her government had contacted the Health Ministry about the possible distribution and use of the Sputnik V vaccine and was currently waiting for its response.

Russia offers Indonesia access to Sputnik vaccine - Sat, October 17 2020 - The Jakarta Post

The latest study, published in The Lancet Infectious Diseases journal, included participants aged between 18 and 80 years, and found that antibody responses were induced in all recipients. The latest study, published in The Lancet Infectious Diseases journal, included participants aged between 18 and 80 years, and found that antibody responses were induced in all recipients.

Chinese COVID-19 vaccine candidate shows promise in human trial: Study

Chinese drug companies have five vaccines in final stages of testing but none is approved for public use. They are part of a global race to develop a vaccine that, if successful, offers the fledgling Chinese industry the potential for prestige and worldwide sales.Chinese drug companies have five vaccines in final stages of testing but none is approved for public use. They are part of a global race to develop a vaccine that, if successful, offers the fledgling Chinese industry the potential for prestige and worldwide sales.

China rapidly expands use of experimental COVID-19 vaccines | World News,The Indian Express

Chinese drug companies have five vaccines in final stages of testing but none is approved for public use. They are part of a global race to develop a vaccine that, if successful, offers the fledgling Chinese industry the potential for prestige and worldwide sales.Chinese drug companies have five vaccines in final stages of testing but none is approved for public use. They are part of a global race to develop a vaccine that, if successful, offers the fledgling Chinese industry the potential for prestige and worldwide sales.

China rapidly expands use of experimental COVID-19 vaccines | World News,The Indian Express

The vaccine, BBIBP-CorV, includes the killed virus mixed with another component, aluminium hydroxide, which is an adjuvant as it is known to boost immune responses.The vaccine, BBIBP-CorV, includes the killed virus mixed with another component, aluminium hydroxide, which is an adjuvant as it is known to boost immune responses.

Chinese Covid vaccine safe in phase 1 & 2 trials, generates antibodies, Lancet says

The vaccine, BBIBP-CorV, includes the killed virus mixed with another component, aluminium hydroxide, which is an adjuvant as it is known to boost immune responses.The vaccine, BBIBP-CorV, includes the killed virus mixed with another component, aluminium hydroxide, which is an adjuvant as it is known to boost immune responses.

Chinese Covid vaccine safe in phase 1 & 2 trials, generates antibodies, Lancet says

NewZimbabwe.com – The Zimbabwe News You Trust is Zimbabwe’s leading online newspaper and published by New Zimbabwe Media Ltd. The platform brings you the latest breaking News, Business, Showbiz, Sports, Diaspora and gives you everything you’ve come to expect and love.Spread This NewsMailOnLine Hopes of getting a Covid-19 vaccine were boosted again today after an experimental Chinese jab was found to be safe and produce an immune response. Every volunteer given a double-dose of state-owned firm Sinopharm’s vaccine made antibodies against SARS-CoV-2, the coronavirus that causes Covid-19. In theory, this would protect them from catching

More Covid-19 vaccine hopes as scientists say experimental Chinese jab is safe - NewZimbabwe.com

COVID-19 vaccine, and China-Africa health cooperation, are their focus.

50 African diplomats visit Chinese coronavirus vaccine maker - CGTN

A $60 double-dose experimental coronavirus vaccine is being made available to some residents in an eastern Chinese city, health officials have said, the first details of a mass rollout for an as-yet unproven vaccine. Officials in Jiaxing city said Thursday residents aged between 18 and 59 with "urgent needs" can seek consultations at clinics for a Sinovac Biotech vaccine thatA $60 double-dose experimental coronavirus vaccine is being made available to some residents in an eastern Chinese city, health officials have said, the first details of a mass rollout for an as-yet

$60 experimental coronavirus vaccine rolled out in eastern Chinese city | Deccan Herald

Participants aged 60 and older were slower to respond, taking 42 days before antibodies were detected in all recipients compared with 28 days for participants aged 18-59Participants aged 60 and older were slower to respond, taking 42 days before antibodies were detected in all recipients compared with 28 days for participants aged 18-59

Preliminary results show Chinese Covid-19 vaccine candidate safe | Dhaka Tribune

The move is aimed at boosting public confidence in homegrown inoculations, the WSJ reported, citing a company website and some students who applied for it.

China's Sinopharm Offers Experimental COVID-19 Vaccines to Students - The Wire Science

The North Carolina Department of Health and Human Services released their interim COVID-19 vaccination plan Friday, once one is available.The North Carolina Department of Health and Human Services released their interim COVID-19 vaccination plan Friday, once one is available.

North Carolina unveils plan to deploy coronavirus vaccine

The potential vaccine, dubbed BBIBP-CorV, is being developed by the Beijing Institute of Biological Products, a subsidiary of China National Biotec GrThe potential vaccine, dubbed BBIBP-CorV, is being developed by the Beijing Institute of Biological Products, a subsidiary of China National Biotec Gr

Coronavirus vaccine candidate from China's CNBG shows promise in human test, study shows - Times of India

Results of BBIBP-CorV vaccine currently underway in UAE will provide information whether it is safe and efficacious.Results of BBIBP-CorV vaccine currently underway in UAE will provide information whether it is safe and efficacious.

Covid-19 vaccine on trial in UAE found safe in early stages: Study - News | Khaleej Times

JAKARTA, Oct 16 (The Jakarta Post/ANN): The Russian government has officially made an offer to the Indonesian government for the use and further development of a coronavirus vaccine, Sputnik V, which is currently in its Phase III clinical trial.JAKARTA, Oct 16 (The Jakarta Post/ANN): The Russian government has officially made an offer to the Indonesian government for the use and further development of a coronavirus vaccine, Sputnik V, which is currently in its Phase III clinical trial.

Russia offers Indonesia access to Sputnik V vaccine for Covid-19 as cases continues to surge; total above 353,000 | The Star

Health authorities in Jiaxing, East China’s Zhejiang Province, announced on Thursday that the city has been administering China’s homegrown inactivated COVID-19 vaccines among high-risk groups and would gradually offer it to ordinary citizens for urgent use.

Eastern Chinese cities to offer ordinary citizens COVID-19 vaccines - Global Times

Clinical trials of the coronavirus vaccine have involved 640 peopleClinical trials of the coronavirus vaccine have involved 640 people

Chinese Covid-19 vaccine candidate safe, early reports say | Metro News

BEIJING • One of China's front-running coronavirus vaccine candidates was shown to be safe and triggered immune responses in a combined early-and mid-stage test in humans, researchers said.. Read more at straitstimes.com.East Asia News -BEIJING • One of China's front-running coronavirus vaccine candidates was shown to be safe and triggered immune responses in a combined early-and mid-stage test in humans, researchers

China vaccine candidate found safe in early tests, East Asia News & Top Stories - The Straits Times

BEIJING, Oct 16 — One of China’s front-running coronavirus vaccine candidates was shown to be safe and triggered immune responses in a combined early and mid-stage test in humans, researchers said. The potential vaccine, dubbed BBIBP-CorV, is being developed by the Beijing Institute of...BEIJING, Oct 16 — One of China’s front-running coronavirus vaccine candidates was shown to be safe and triggered immune responses in a combined early and mid-stage test in humans, researchers said. The potential vaccine, dubbed BBIBP-CorV, is being developed by the Beijing Institute of...

Study: Covid-19 vaccine candidate from China’s CNBG shows promise in human test | Life | Malay Mail

Hope for a coronavirus vaccine have been boosted after a Chinese jab proved to be safe and produced an antibody response, scientists have said. The research, published in the journal Lancet Infectious Disease, is based on small early phase randomised clinical trials involving 640 participants. The vaccine candidate is based on inactivated coronavirus. Scientists said thoseHope for a coronavirus vaccine have been boosted after a Chinese jab proved to be safe and produced an antibody response, scientists have said. The research, published in the journal Lancet

Hope for coronavirus vaccine boosted as scientists say Chinese jab safe and produces immune response | London Evening Standard

Researchers said those aged 60 and over were slower to respond to the BBIBP-CorV vaccine.Researchers said those aged 60 and over were slower to respond to the BBIBP-CorV vaccine.

Chinese Covid-19 vaccine candidate 'safely triggers antibody response' | ITV News

RUSSIA has approved its second coronavirus vaccine for general use from the public, but has again not subjected the drug to mass safety testingRUSSIA has approved its second coronavirus vaccine for general use from the public, but has again not subjected the drug to mass safety testing

Coronavirus vaccine shock as Russia approves SECOND jab without safety tests | World | News | Express.co.uk

China has begun inoculating the general public against the coronavirus with an experimental vaccine that has not yet completed clinical trials.Health officials in Jiaxing, Zhejiang province, said theChina has begun inoculating the general public against the coronavirus with an experimental vaccine that has not yet completed clinical trials.Health officials in Jiaxing, Zhejiang province, said the

Researchers caution that levels of antibodies produced in participants aged over 60 were lower and took longer to increase, however Researchers caution that levels of antibodies produced in participants aged over 60 were lower and took longer to increase, however 

Chinese coronavirus vaccine shows promising results in human tests, study shows | The Independent

Key workers and those at high risk from COVID-19 would be among the first to receive the jabs in the city of Jiaxing. Others include residents aged between 18 and 59 with 'urgent need for vaccination'.Key workers and those at high risk from COVID-19 would be among the first to receive the jabs in the city of Jiaxing. Others include residents aged between 18 and 59 with 'urgent need for vaccination'.

Coronavirus: Experimental £46 COVID-19 vaccine is made available to residents of Chinese city | Daily Mail Online

BEIJING: A US$60 double-dose experimental COVID-19 vaccine is being made available to some residents in an eastern Chinese city, health officials ...BEIJING: A US$60 double-dose experimental COVID-19 vaccine is being made available to some residents in an eastern Chinese city, health officials ...

US$60 experimental COVID-19 vaccine rolled out in east Chinese city - CNA

A €50 double-dose experimental coronavirus vaccine is being made available to some residents in an eastern Chinese city, health officials have said, the first details of a mass rollout for an as-yet unproven vaccine. Officials in Jiaxing city said that residents aged between 18 and 59 with...A €50 double-dose experimental coronavirus vaccine is being made available to some residents in an eastern Chinese city, health officials have said, the first details of a mass rollout for an as-yet unproven vaccine. Officials in Jiaxing city said that residents aged between 18 and 59 with...

€50 experimental COVID-19 vaccine rolled out in east Chinese city

In August, Russia registered the world’s first vaccine against the coronavirus, which was highly praised by health experts across the globe and evaluated in the...In August, Russia registered the world’s first vaccine against the coronavirus, which was highly praised by health experts across the globe and evaluated in the...

'No Adverse Effects': Russian Minister on Why He Chose COVID Vaccine Based on Human Adenovirus - Sputnik International

The State Council will be headed by the Russian president. It will serve as an advisory body to the head of stateThe State Council will be headed by the Russian president. It will serve as an advisory body to the head of state

Putin introduces draft bill on creation of State Council to Russian parliament - Russian Politics & Diplomacy - TASS

Putin introduces draft bill on creation of State Council to Russian parliament

During a televised meeting with government officials on Wednesday, Russian President Vladimir Putin announced that the country has registered the second Covid-19 vaccine.During a televised meeting with government officials on Wednesday, Russian President Vladimir Putin announced that the country has registered the second Covid-19 vaccine.

After Sputnik V, Russia approves 2nd Covid-19 vaccine EpiVacCorona; Putin says 3rd one almost ready

Registration of the third candidate preparation is due shortly, according to the presidentRegistration of the third candidate preparation is due shortly, according to the president

Vector center registers second Russian COVID-19 vaccine - Society & Culture - TASS

Vector center registers second Russian COVID-19 vaccine

A vaccine developed by the Vector State Virology and Biotechnology Centre in Siberia has been registered, President Putin said in televised comments W..A vaccine developed by the Vector State Virology and Biotechnology Centre in Siberia has been registered, President Putin said in televised comments W..

covid-19: Russia green lights 2nd vaccine before Ph-3 trials, Health News, ET HealthWorld

It has only been tested in 100 people, and there's no published data.It has only been tested in 100 people, and there's no published data.

Putin touts second dubious approval of an unproven COVID-19 vaccine | Ars Technica